1-(Pyridin-3-yl)-1H-pyrazole-3-carboxylic acid:Exports & Compliance White Paper 2026

I. Executive Summary

1-(Pyridin-3-yl)-1H-pyrazole-3-carboxylic acid (CAS 1014631-62-9) is a bicyclic heteroaryl building block of formula C9H7N3O2 and molecular weight 189.17 g/mol, combining an N1-linked pyridin-3-yl ring with a pyrazole bearing a carboxylic acid at C3. The architecture delivers three orthogonal handles: a nucleophilic pyridine nitrogen, a carboxyl group amenable to amide coupling, and a CH-acidic, halogenation-ready pyrazole ring. This is why the substance recurs in medicinal and agrochemical discovery, where the pyrazole carboxamide motif is one of the most productive pharmacophores of the last two decades.

Commercially the compound is a classic registered-intermediate transaction. Buyers are not purchasing a molecule so much as a regiochemically defined, metal-controlled, documentation-backed position on a heterocycle scaffold. Three technical issues dominate every specification: control of the 3- versus 5-carboxylate regioisomer, control of residual palladium and copper from the N-arylation step, and control of hydrazine-derived and alkylating impurities, which are mutagenicity alerts under ICH M7 rather than ordinary related substances.

This white paper treats the material strictly as a chemical intermediate and research building block. It is not an active pharmaceutical ingredient, not a finished formulation and not a consumer product; no therapeutic, agricultural-efficacy or human-use claim is made or implied. Where GMP is discussed, it refers to the quality system applied to intermediate manufacture under ICH Q7 and to customer audit expectations, not to any approved medicinal use.

II. Product Deep Dive: Molecular Mechanisms and Production Evolution

2.1 Physicochemical Properties and Mechanisms

The molecule is a high-melting, poorly water-soluble solid, typically isolated as a free-flowing off-white to pale-yellow powder after controlled crystallisation. The pyridine nitrogen and the carboxylic acid give pH-dependent solubility and salt formation, which is the practical basis for both purification and use as a coupling partner. Amide formation at C3 proceeds through standard activation chemistry, and the pyrazole ring tolerates electrophilic halogenation at C4 in downstream steps.

• Regiochemistry Defines Value: Because N1 is substituted, the 3-carboxylate and 5-carboxylate isomers are distinct, non-interconverting compounds with different vector geometry; an isomer error propagates into every downstream intermediate and is essentially impossible to correct later. Buyers should require isomer-specific identification by 1H and 13C NMR plus a chromatographic method resolved for the isomer, not a generic "assay by HPLC" result.
• Metal and Hydrazine Legacy: N-Arylation of the pyrazole nitrogen almost always proceeds through copper-catalysed Ullmann-type or palladium-catalysed Buchwald-Hartwig coupling, leaving metal residues that must meet ICH Q3D limits in a regulated synthesis. Hydrazine or aryl-hydrazine reagents used to construct the ring are mutagenicity alerts and must be purged and tested under an ICH M7 control strategy, not merely diluted below an assay threshold.

2.2 Synthesis and Manufacturing Technologies

Two strategic disconnections dominate manufacture, and the choice between them is the single determinant of regiochemical outcome. Either the pyrazole ring is constructed first and the pyridine installed by N-arylation, or the pyridyl fragment is carried on the hydrazine component and the ring closed onto it. The second approach generally gives cleaner regiocontrol but requires a substituted pyridylhydrazine, which carries its own cost and genotoxicity handling burden.

• Cyclocondensation and N-Arylation: Knorr-type condensation of a hydrazine with a 1,3-dicarbonyl or an alkoxalyl-acetate equivalent gives the pyrazole-3-carboxylate ester, followed by copper- or palladium-catalysed N-arylation with a 3-halopyridine and saponification of the ester. Route discipline focuses on N1/N2 selectivity, suppression of di-arylation, control of the ester hydrolysis and removal of the catalyst metal by chelation or carbon treatment.
• Purification and Analytical Control: Recrystallisation from alcoholic or aqueous-alcoholic systems, acid-base reprecipitation and, for high-value lots, preparative chromatography deliver 97% research-grade and 99% or better qualified material. Release testing combines HPLC assay and related substances, NMR identity and isomer confirmation, LC-MS for unknown impurities, Karl Fischer water, residual solvents by headspace GC, ICP-MS metals and, where the route warrants it, a dedicated hydrazine-specific method with derivatisation.

2.3 Core Application Matrix

• Pharmaceutical Intermediates — Kinase and Anti-Inflammatory Programs: The pyrazole carboxamide is a privileged hinge-binding and amide-vector motif in kinase inhibitor and anti-inflammatory discovery; this acid is used to install the pyridyl-pyrazole carboxamide fragment early in a route. Supply into this channel requires impurity rationale, metal data and, later in development, a validated method and change-control agreement.
• Agrochemical Intermediates — Diamide and Carboxamide Classes: Pyridyl-pyrazole carboxylic acids are the defining acid fragment of anthranilic diamide insecticides, and the pyrazole carboxamide unit recurs across succinate-dehydrogenase-inhibitor and related fungicide families. Volumes here are larger and price pressure is sharper, but the impurity and metal expectations of multinational agrochemical registrants are close to pharmaceutical ones.
• Research and Custom-Synthesis Feedstock: Catalog and custom-synthesis supply serves discovery chemistry, library synthesis, metabolite and reference-standard preparation, and process-route scouting. Requirements are speed, small-lot flexibility, structural confirmation and reliable documentation rather than tonnage, making this the natural entry point before qualification into campaign supply.

III. Global Market Supply-Demand Landscape and Export Trends

3.1 Demand Drivers and Market Shifts

Demand tracks discovery and registration pipelines rather than macroeconomic cycles. Pharmaceutical demand is programme-linked: a single candidate entering Phase II can absorb multi-kilogram quantities within a year, and the same programme terminating removes the demand abruptly. Agrochemical demand is more durable but lumpy, driven by launch timing, patent cliffs and, increasingly, by the regulatory re-registration of existing carboxamide actives in Europe, which sustains intermediate volumes long after the original patent has expired.

3.2 Capacity Distribution and Export Flows

Heterocycle capacity is concentrated in Asian multipurpose plants. Chinese producers in Jiangsu, Shandong, Zhejiang and Shanghai offer the broadest reagent base and shortest route-development cycles, increasingly running dedicated campaigns under quality agreements. Indian CDMOs around Hyderabad, Ahmedabad and Bangalore combine heterocyclic chemistry with English regulatory dossiers and long-standing agrochemical relationships. European custom-synthesis houses serve early-phase and high-compliance work where proximity, IP protection and auditability outweigh unit cost.

3.3 Market Bifurcation and Pricing Dynamics

The market splits into catalog grams, non-GMP kilogram intermediates and GMP or qualified campaign material, with order-of-magnitude price steps between them. The step is not explained by synthesis difficulty but by analytical and systems cost: method development and validation, metal and mutagenicity control, cleaning validation, documentation packages and audit hosting. Buyers who compare quotations across tiers without comparing deliverables consistently misjudge value, and re-work caused by an inadequate first lot usually costs more than the tier differential.

IV. In-depth Analysis of Global Compliance and Regulatory Barriers

As an intermediate, the substance is regulated mainly through general chemical law rather than product authorisation. The practical obligations are inventory status in the destination market, correct classification and labelling, an accurate safety data sheet, and the quality agreements that the buyer's own regulated filing imposes. Because the compound is not itself an approved active substance, compliance burden is transferred downstream and varies sharply between a discovery purchase and a commercial campaign.

4.1 European Market: REACH, CLP, and Sector-Specific Directives

• REACH Registration Status and Intermediate Exemptions: Volumes above one tonne per year generally require a full registration unless a legitimate intermediate exemption applies, and the status, tonnage band and registrant identity must be confirmed with the supplier before contracting. Many such heterocycles are supplied under strictly controlled intermediate conditions or below registration threshold, so an importer should verify whether its own placing on the market triggers an obligation rather than assume the exporter has covered it.
• CLP Classification, SDS and Downstream Obligations: Heteroaryl carboxylic acids of this type are commonly classified for skin and serious eye irritation and for specific target organ toxicity following single exposure, principally respiratory-tract effects from dust. That drives GHS labelling, dust-control expectations and extended safety data sheet requirements, including any applicable nanoform or exposure-scenario obligations; classification must be checked against the current harmonised and notified entries rather than assumed from a supplier's older document.

4.2 North American Market: TSCA, EPA, and FDA Regulations

• TSCA Inventory and New-Chemical Position: Commercial import into the United States requires the substance to be on the TSCA Chemical Substance Inventory; if it is not, a premanufacture notice or a low-volume or low-release exemption is needed before shipment, and significant-new-use rules may restrict the permitted handling. Because inventory status for comparatively recent CAS registrations is sometimes contested, importers should obtain written confirmation supported by the inventory listing rather than a trader's assertion.
• ICH-Driven Quality Expectations: For material entering a regulated synthesis, the buyer's filing governs: ICH Q7 for intermediate manufacture, ICH Q11 for development and manufacture of the drug substance, ICH Q3C for residual solvents and ICH Q3D for elemental impurities, with palladium, copper and nickel the metals of concern from this chemistry. Suppliers are expected to supply a route description, impurity rationale, metal data and a change-control commitment rather than only a certificate of analysis.

4.3 The Critical Hurdle: Quality Control and Safety Limits

V. Green Trade Barriers and ESG in Manufacturing

Heterocycle synthesis carries a conventional but real environmental profile: polar aprotic solvents, metal catalysts, inorganic bases and multi-stage aqueous work-ups. Multinational customers now screen suppliers on solvent-recovery performance, metal recovery, wastewater treatment and energy intensity, and routinely apply supplier codes of conduct that extend to the intermediate level even where no legal obligation exists.

5.1 Carbon Footprint and Circular Economy

Meaningful improvement comes from solvent recovery and reuse, telescoping stages to avoid isolation of intermediates, replacing high-boiling polar aprotic solvents where chemistry permits, and recovering copper and precious metal from spent catalyst streams. Producers operating under ISO 14001 and ISO 50001 and able to report Scope 1, 2 and material Scope 3 emissions in auditable form are measurably better placed when corporate buyers apply European sustainability reporting and supply-chain due-diligence expectations to upstream inputs.

5.2 Sustainable Sourcing and Traceability

Traceability for a building block means a documented route, named raw materials, batch genealogy, retained samples and a certificate chain that survives customer audit. Buyers should require conflict-mineral and sanctions screening, a statement on catalyst-metal provenance and recovery, and confirmation that no undisclosed subcontracting or re-packing has occurred, since unauthorised blending of lots is the most common cause of certificate and genealogy inconsistencies discovered during qualification.

VI. Supply Chain Resilience and Export Logistics

The compound is a stable crystalline solid, so logistics risk is dominated by moisture uptake, dust generation and documentation rather than inherent instability. Carboxylic acids and heteroaryl solids can cake, discolour or pick up water if packaged poorly, and customers running moisture-sensitive coupling chemistry reject lots on water content even when assay is unaffected.

6.1 Packaging Standards and Moisture/Contamination Control

• Barrier Packaging and Desiccation: Double low-density polyethylene liners inside fibre drums or HDPE pails, closed under low humidity with desiccant where the specification demands it, are the practical standard. Antistatic liners and conductive drum types are preferred for fine powders, because the material is dust-forming and electrostatic handling complicates both weighing and containment.
• Lot Integrity and Documentation: Research lots ship in 100 g to 5 kg packs and campaign lots in 25 kg drums, each with a unique lot number, tamper-evident seal and retained sample. Certificates should state lot-specific assay, isomer purity, water, metals and residual solvents, and any re-pack by a distributor without manufacturer authorisation voids genealogy and should be refused by the buyer.

6.2 Dangerous Goods Identification and Transit Protocols

Most suppliers classify this material as not dangerous for transport under IMO, ADR and IATA, but the classification must be confirmed against the current safety data sheet and, where any classification applies, matched to the correct packing instruction and labelling. Sea freight in sealed drums is normal for bulk, air freight is routine for high-value small lots, and controlled ambient conditions are generally sufficient; cold chain is required only where the supplier's own stability data defines it. Consignments should travel with a compliant safety data sheet, a certificate of analysis and, for regulated customers, a handling and containment note addressing dust control.

VII. Enterprise Global Expansion Strategy Guide

Suppliers win in this category by removing technical risk from the buyer's programme rather than by discounting. The three moves below are ordered by how directly they convert into qualified, repeat business.

1. Sell the Regiochemical and Metal Package: Publish an isomer-resolved specification with explicit limits for the alternative carboxylate, di-arylated by-product, residual hydrazine species and catalyst metals, and validate the method rather than relying on a screening gradient. This converts a commodity quotation into a technical proposal and is usually the deciding factor in supplier selection for development campaigns.
2. Offer Tiered GMP and Documentation: Run a non-GMP route for discovery volumes and a documented, ICH Q7-aligned route for qualified campaigns, with a defined upgrade path, change-control policy and audit access. Customers rarely want GMP at gram scale, but they do want assurance that the route that will later supply the campaign is already the route being run.
3. Build Inventory and Route Resilience: Hold safety stock of the key pyridyl and hydrazine raw materials, qualify a second source for the 3-halopyridine, and maintain both copper and palladium variants of the N-arylation step so that catalyst cost and metal-specification conflicts can be resolved without a route change and re-validation.

VIII. Conclusion

1-(Pyridin-3-yl)-1H-pyrazole-3-carboxylic acid is a scaffold-building block whose value lies almost entirely in precision: correct carboxylate position, controlled metal legacy and a defensible position on hydrazine-derived impurities. Its demand is anchored in two of the most productive families of modern discovery chemistry, pyrazole carboxamide pharmaceuticals and pyridyl-pyrazole agrochemicals, an anchoring more durable than the individual programmes generating any given order.

Buyers should procure against an isomer-resolved, metal-controlled specification, confirm inventory and classification status in writing for each destination, and require genealogy that survives audit. This paper is for business-to-business sourcing and compliance planning only. The compound is a chemical intermediate and research building block; it is not an active substance or finished formulation and not for human or veterinary use, and no therapeutic or agricultural-efficacy claim is made.

IX. Industry Resource Connection and Supplier Ecosystem

Powered by Guidechem

This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.

Guidechem Global 1-(Pyridin-3-yl)-1H-pyrazole-3-carboxylic acid Supplier Ecosystem List

Relying on Guidechem's extensive global database, we have mapped the core participants in the current global 1-(Pyridin-3-yl)-1H-pyrazole-3-carboxylic acid supply chain:

• China — Heterocycle Multipurpose Clusters: Producers in Jiangsu, Shandong, Zhejiang and Shanghai combine the broadest reagent availability with rapid route development and flexible campaign scheduling, serving both catalog quantities and multi-kilogram custom supply. The typical qualification gap is documentation depth and English regulatory dossiers rather than synthetic capability.
• India — Agrochemical-Linked CDMO Base: CDMOs around Hyderabad, Ahmedabad and Bangalore pair heterocyclic and amidation chemistry with mature agrochemical-customer relationships and English-language quality documentation. Strengths are process optimisation, cost engineering and registration-support experience; watch-points are solvent-recovery and effluent practice consistency between sites.
• Europe — Early-Phase and High-Compliance Custom Synthesis: German, Swiss, Italian and British custom-synthesis houses serve discovery and early-development volumes where intellectual-property protection, auditability and proximity to the sponsor outweigh unit cost. Their role is typically route invention, analytical development and first GMP campaigns before transfer to lower-cost partners.